These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8406980)

  • 21. Prediction of superficial bladder cancer by histoquantitative methods.
    Lipponen PK; Eskelinen MJ; Sotarauta M
    Eur J Cancer; 1990; 26(10):1060-3. PubMed ID: 2148881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of morphometric nuclear image analysis using the Feulgen reaction in renal cell carcinoma.
    Lee JS; Jung JJ; Lee MC; Park CS; Juhng SW; Oh BR; Moon JD
    Anal Quant Cytol Histol; 2000 Feb; 22(1):31-6. PubMed ID: 10696458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear quantitative grading by discriminant analysis of renal cell carcinoma samples. A patient survival evaluation.
    Artacho-Pérula E; Roldán-Villalobos R; Martínez-Cuevas JF; López-Rubio F
    J Pathol; 1994 Jun; 173(2):105-14. PubMed ID: 8089804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Independent prognostic factors in T2/T3 transitional cell bladder tumours with special reference to histoquantitative methods.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S
    Surg Oncol; 1992 Apr; 1(2):135-43. PubMed ID: 1341244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in axillary lymph node-negative (pN-) breast carcinomas.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Eur J Cancer; 1991; 27(12):1555-9. PubMed ID: 1782062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer.
    Lipponen PK; Collan Y; Eskelinen MJ; Pesonen E; Sotarauta M; Nordling S
    Br J Urol; 1990 Jun; 65(6):589-97. PubMed ID: 2372672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in nodular transitional cell bladder tumours.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    Scand J Urol Nephrol; 1993; 27(2):205-10. PubMed ID: 8351473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
    Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in human pancreatic cancer, with special reference to quantitative histology.
    Eskelinen M; Lipponen P; Marin S; Haapasalo H; Mäkinen K; Ahtola H; Puittinen J; Nuutinen P; Alhava E
    Scand J Gastroenterol; 1991 May; 26(5):483-90. PubMed ID: 1651557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Qualitative and quantitative parameters for prognosis in renal carcinoma in early and advanced stages].
    Del Vecchio MT; Spina D; Lazzi S; Bruni A; Funtò I; Mattei FM; Fornaini M; Luzi P; Tosi P
    Pathologica; 1997 Aug; 89(4):390-6. PubMed ID: 9471607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereologically measured nuclear volume in comparison to two-dimensional nuclear morphometry, mitotic index and flow cytometry in predicting disease outcome in bladder cancer.
    Lipponen PK
    Anticancer Res; 1993; 13(2):529-32. PubMed ID: 8517668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative histopathology in the prognostic evaluation of patients with transitional cell carcinoma of the urinary bladder.
    Sasaki M; Sørensen FB; Fukuzawa S; Yamabe H; Olsen S; Yoshida O
    Cancer; 1993 Oct; 72(8):2470-83. PubMed ID: 8402464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
    Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
    J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.
    van der Poel HG; Mulders PF; Oosterhof GO; Schaafsma HE; Hendriks JC; Schalken JA; Debruyne FM
    Cancer; 1993 Nov; 72(9):2667-74. PubMed ID: 8402488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in prostatic adenocarcinoma assessed by means of quantitative histology.
    Eskelinen M; Lipponen P; Majapuro R; Syrjänen K
    Eur Urol; 1991; 19(4):274-8. PubMed ID: 1915532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.
    Lipponen PK; Aaltomaa S
    J Pathol; 1994 Aug; 173(4):333-9. PubMed ID: 7965393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of a morphometric prognostic index in female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Oncology; 1993; 50(1):57-62. PubMed ID: 8421599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitotic activity and prognosis in prostatic adenocarcinoma.
    Vesalainen S; Lipponen P; Talja M; Syrjänen K
    Prostate; 1995 Feb; 26(2):80-6. PubMed ID: 7855001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computerized nuclear morphometry and survival in renal cell carcinoma: comparison with other prognostic indicators.
    Delahunt B; Becker RL; Bethwaite PB; Ribas JL
    Pathology; 1994 Oct; 26(4):353-8. PubMed ID: 7892031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear shape analysis for assessment of prognosis in renal cell carcinoma.
    Murphy GF; Partin AW; Maygarden SJ; Mohler JL
    J Urol; 1990 Jun; 143(6):1103-7. PubMed ID: 2342168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.